Methyldopa Remedica (Anhydrous Methyldopa)

Methyldopa acts as a central alpha‑2 adrenergic receptor agonist. Stimulation of these presynaptic receptors in the brainstem reduces the release of norepinephrine, decreasing sympathetic nervous system activity. The resulting vasodilation and lowered peripheral resistance lead to a reduction in systemic blood pressure.

The specific dose of Methyldopa Remedica is determined by the prescribing clinician based on the individual’s blood‑pressure profile, age, renal function, and response to therapy. Dosage adjustments are made during treatment to achieve optimal control while minimizing side effects.

Methyldopa is classified as Pregnancy Category B, indicating that animal studies have not shown risk to the fetus and there are no well‑controlled human studies. It is commonly used for gestational hypertension. Limited data are available for breastfeeding; the decision to continue should be made by the healthcare provider weighing benefits and potential risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature‑controlled logistics) and necessary import documentation.

Methyldopa is a centrally acting agent, whereas many antihypertensives such as ACE inhibitors, calcium‑channel blockers, and diuretics act peripherally. Its advantage lies in safety during pregnancy, a setting where many other classes are contraindicated. However, it may cause more central side effects like sedation and requires careful monitoring compared with newer agents.

Methyldopa tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the container tightly closed and out of reach of children. No refrigeration is required for this oral formulation.

Methyldopa Remedica is taken orally, usually with food or a glass of water to reduce gastrointestinal irritation. The tablet should be swallowed whole and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious adverse events include severe hypotension, liver dysfunction (elevated enzymes or hepatitis), and hemolytic anemia. Patients should report symptoms such as sudden dizziness, yellowing of the skin or eyes, dark urine, or unexplained fatigue to their clinician promptly.

Methyldopa is contraindicated in individuals with known hypersensitivity to the drug or any component of the formulation. Caution is advised for patients with severe liver disease, active depression, or those taking MAO inhibitors. Pregnant or breastfeeding patients should only use it under medical supervision.